Cargando…

Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion

BACKGROUND: This research aimed to develop a model for individualized treatment decision-making in inoperable elderly patients with esophageal squamous cell carcinoma (ESCC) using machine learning methods and multi-modal data. METHODS: A total of 189 inoperable elderly ESCC patients aged 65 or older...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong, Huang, Xiaoyu, Wang, Anling, Chen, Qiwei, Chen, Gong, Ye, Jingya, Wang, Yaru, Qin, Zhihui, Xu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594800/
https://www.ncbi.nlm.nih.gov/pubmed/37872517
http://dx.doi.org/10.1186/s12911-023-02339-5
_version_ 1785124727109451776
author Huang, Yong
Huang, Xiaoyu
Wang, Anling
Chen, Qiwei
Chen, Gong
Ye, Jingya
Wang, Yaru
Qin, Zhihui
Xu, Kai
author_facet Huang, Yong
Huang, Xiaoyu
Wang, Anling
Chen, Qiwei
Chen, Gong
Ye, Jingya
Wang, Yaru
Qin, Zhihui
Xu, Kai
author_sort Huang, Yong
collection PubMed
description BACKGROUND: This research aimed to develop a model for individualized treatment decision-making in inoperable elderly patients with esophageal squamous cell carcinoma (ESCC) using machine learning methods and multi-modal data. METHODS: A total of 189 inoperable elderly ESCC patients aged 65 or older who underwent concurrent chemoradiotherapy (CCRT) or radiotherapy (RT) were included. Multi-task learning models were created using machine learning techniques to analyze multi-modal data, including pre-treatment CT images, clinical information, and blood test results. Nomograms were constructed to predict the objective response rate (ORR) and progression-free survival (PFS) for different treatment strategies. Optimal treatment plans were recommended based on the nomograms. Patients were stratified into high-risk and low-risk groups using the nomograms, and survival analysis was performed using Kaplan–Meier curves. RESULTS: The identified risk factors influencing ORR were histologic grade (HG), T stage and three radiomic features including original shape elongation, first-order skewness and original shape flatness, while risk factors influencing PFS included BMI, HG and three radiomic features including high gray-level run emphasis, first-order minimum and first-order skewness. These risk factors were incorporated into the nomograms as independent predictive factors. PFS was substantially different between the low-risk group (total score ≤ 110) and the high-risk group (total score > 110) according to Kaplan–Meier curves (P < 0.05). CONCLUSIONS: The developed predictive models for ORR and PFS in inoperable elderly ESCC patients provide valuable insights for predicting treatment efficacy and prognosis. The nomograms enable personalized treatment decision-making and can guide optimal treatment plans for inoperable elderly ESCC patients.
format Online
Article
Text
id pubmed-10594800
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105948002023-10-25 Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion Huang, Yong Huang, Xiaoyu Wang, Anling Chen, Qiwei Chen, Gong Ye, Jingya Wang, Yaru Qin, Zhihui Xu, Kai BMC Med Inform Decis Mak Research BACKGROUND: This research aimed to develop a model for individualized treatment decision-making in inoperable elderly patients with esophageal squamous cell carcinoma (ESCC) using machine learning methods and multi-modal data. METHODS: A total of 189 inoperable elderly ESCC patients aged 65 or older who underwent concurrent chemoradiotherapy (CCRT) or radiotherapy (RT) were included. Multi-task learning models were created using machine learning techniques to analyze multi-modal data, including pre-treatment CT images, clinical information, and blood test results. Nomograms were constructed to predict the objective response rate (ORR) and progression-free survival (PFS) for different treatment strategies. Optimal treatment plans were recommended based on the nomograms. Patients were stratified into high-risk and low-risk groups using the nomograms, and survival analysis was performed using Kaplan–Meier curves. RESULTS: The identified risk factors influencing ORR were histologic grade (HG), T stage and three radiomic features including original shape elongation, first-order skewness and original shape flatness, while risk factors influencing PFS included BMI, HG and three radiomic features including high gray-level run emphasis, first-order minimum and first-order skewness. These risk factors were incorporated into the nomograms as independent predictive factors. PFS was substantially different between the low-risk group (total score ≤ 110) and the high-risk group (total score > 110) according to Kaplan–Meier curves (P < 0.05). CONCLUSIONS: The developed predictive models for ORR and PFS in inoperable elderly ESCC patients provide valuable insights for predicting treatment efficacy and prognosis. The nomograms enable personalized treatment decision-making and can guide optimal treatment plans for inoperable elderly ESCC patients. BioMed Central 2023-10-23 /pmc/articles/PMC10594800/ /pubmed/37872517 http://dx.doi.org/10.1186/s12911-023-02339-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Yong
Huang, Xiaoyu
Wang, Anling
Chen, Qiwei
Chen, Gong
Ye, Jingya
Wang, Yaru
Qin, Zhihui
Xu, Kai
Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title_full Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title_fullStr Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title_full_unstemmed Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title_short Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
title_sort individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594800/
https://www.ncbi.nlm.nih.gov/pubmed/37872517
http://dx.doi.org/10.1186/s12911-023-02339-5
work_keys_str_mv AT huangyong individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT huangxiaoyu individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT wanganling individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT chenqiwei individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT chengong individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT yejingya individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT wangyaru individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT qinzhihui individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion
AT xukai individualizedtreatmentdecisionmodelforinoperableelderlyesophagealsquamouscellcarcinomabasedonmultimodaldatafusion